Evidence map›Paper›PMID 30192839›Full record

ArticlePloS one2018

Assessing the performance of only HRP2 and HRP2 with pLDH based rapid diagnostic tests for the diagnosis of malaria in middle Ghana, Africa.

Dennis Adu-Gyasi, Kwaku Poku Asante, Sabastina Amoako, Nicholas Amoako, Love Ankrah, David Dosoo, Samuel Kofi Tchum, George Adjei, Oscar Agyei, Seeba Amenga-Etego and 1 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dennis Adu-GyasiKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.ORCID 0000-0002-9449-2565
Kwaku Poku AsanteKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Sabastina AmoakoKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Nicholas AmoakoKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Love AnkrahKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
David DosooKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Samuel Kofi TchumKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
George AdjeiKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Oscar AgyeiKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Seeba Amenga-EtegoKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.
Seth Owusu-AgyeiKintampo Health Research Centre, Ghana Health Service, Kintampo, Brong Ahafo, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapid diagnostic test (RDT) kits have been useful tools to screen for the presence of infection with malaria parasites. Despite the improvement, false results from RDTs present a greater challenge. The need for quality test kits is desirable. We evaluated the diagnostic accuracy of three malaria RDTs.

methodThe team consented and enrolled 754 participants from the two major public hospitals in Kintampo districts of Ghana from June 2014 to August 2014. Venous blood samples were obtained by trained personnel and samples were screened for malaria using CareStart and SD Bioline HRP2 and HRP2 with pLDH based RDTs with blood slides for malaria microscopy as "gold standard". Geometric mean parasite densities were estimated and parasite densities were used to estimate the quantitative limits of the RDTs. The sensitivities, specificities and other performance criteria were calculated using statistical analytical software.

resultThe median age of participants was 21 (range 5-31) years. There were 28.6% (215/752) were males and 71.4% (537/752) were females. Comparing with microscopy, the sensitivity, specificity, positive predictive value, negative predictive value and the ROC were for CareStart (HRP2), 98.2%, 66.5%, 82.6%, 95.6%, 0.82; for CareStart (HRP2/pLDH) 98.2%, 66.5%, 82.6%, 95.6%, 0.82 and for SD-Bioline (HRP2/pLDH) RDTs 98.2%, 69.2%, 84.2%, 96.0%, 0.84 respectively. The performance for all the kits were acceptable at a cut-off of 25 or more parasites/μl of blood.

conclusionsThe diagnostic performance of the three malaria RDTs was acceptable, according to the World Health Organisation criteria, to detect densities ≥25 parasite/μl of blood. The RDTs with HRP2/pLDH targets were comparable to those with only HRP2 and could successfully substitute current and commonly used HRP2-based RDTs.

Indexed as

AdolescentAdultAntigens, ProtozoanChildCross-Sectional StudiesDiagnostic Tests, RoutineFemaleGhanaHumansL-Lactate DehydrogenaseMalaria, FalciparumMalePlasmodium falciparumProtozoan ProteinsReagent Kits, DiagnosticReproducibility of ResultsAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumL-Lactate DehydrogenaseProtozoan ProteinsReagent Kits, Diagnostic

Identifiers

PMID30192839
PMCPMC6128572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.